Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 563Neoplasms 462Carcinoma, Non-Small-Cell Lung 422Prostatic Neoplasms 344Colorectal Neoplasms 325Lung Neoplasms 269Multiple Myeloma 235Neoplasm Metastasis 197Pancreatic Neoplasms 189Leukemia, Myeloid, Acute 187Ovarian Neoplasms 182Melanoma 153Squamous Cell Carcinoma of Head and Neck 143Head and Neck Neoplasms 121Recurrence 119Carcinoma, Renal Cell 119Carcinoma, Hepatocellular 119Stomach Neoplasms 116Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Glioblastoma 114Endometrial Neoplasms 114Lymphoma 113Brain Neoplasms 111Lymphoma, Non-Hodgkin 108Uterine Cervical Neoplasms 101Triple Negative Breast Neoplasms 99Hematologic Neoplasms 98Urinary Bladder Neoplasms 97Glioma 91Leukemia, Lymphocytic, Chronic, B-Cell 88

Interventions

enasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × 30 days × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2026-05-20

RABBIT

University of Arizona

Phase 1/2 Recruiting
30 enrolled
CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡